category -

CE Mark for Intraocular Lenses: Step-by-Step Guide under EU MDR 2017/745

Learn how to obtain CE marking for intraocular lenses (IOLs) under EU MDR 2017/745, covering Class III classification, clinical evaluation, ISO 13485, technical documentation, Notified Body assessment, and post-market compliance.

Published :

July 14, 2026

Updated :

November 18, 2026

Published :

July 14, 2026

Updated :

November 18, 2026

CE Mark for Intraocular Lenses
CE Marking for Intraocular Lenses – EU MDR Class III Certification and Compliance Guide
Table of Contents
Picture of by Sanket Bharat Bhadange
by Sanket Bharat Bhadange

Senior Regulatory Affairs Executive
4 Years of Experience Medical device regulatory professional specializing in EU MDR 2017/745

Intraocular Lenses are Class III medical devices therefore they must comply fully with medical device legislation (EU MDR 2017/745). In order do so there is a stringent conformity assessment carried out by an designated Notified Body. They must also have an ISO 13485 Quality Management System. The device must undergo Clinical Evaluation (Annex XIV) (ISO 14155 clinical investigations ), Biocompatibility, Optical Performance and Sterility Validation. Additional requirements are required in Germany with the implementation of the Medical Device Implementation Act (MPDG), EUDAMED and Post Market Surveillance (BfArM).

Let's Grow Your Business Together

What Is a CE Mark for Intraocular Lenses (IOL)?

Intraocular Lenses (IOLs) are one of the most common types of implantable medical devices used in Ophthalmology. They can be implanted to replace the original lens of the eye, usually following Cataract surgery or Refractive correction. In order to legally market Intraocular Lenses throughout the European Union including Germany (a key European hub for innovation in Ophthalmology), manufacturers must gain CE Mark for Intraocular Lenses under European Union MDR 2017/745.

CE Mark (Conformité Européenne) is an essential certification that guarantees that Intraocular Lenses meet stringent safety, performance and quality standards. As Intraocular Lenses are permanently implanted into the human eye, there are strict regulations surrounding this type of implant. If Intraocular Lenses have not been CE certified, they will not be able to be legally marketed throughout the European Union (EU). Manufacturers wishing to market their products in several regions will often design their dossiers in Europe to meet global product registration requirements.

Step-by-Step Process to Obtain CE Mark for Intraocular Lenses

There are 7 steps required for obtaining CE certification on Ophthalmic implants.

1. Classification

Intraocular Lenses are considered Class III implants, as defined by EU MDR 2017/745 (Annex VIII). The first step is to ensure your device is correctly classified.

2. Quality Management System

A Quality Management System (QMS) must be put in place. The QMS must comply with ISO 13485 and other international medical device standards. This will ensure that your product is consistently designed, manufactured in a clean room environment and maintained to a high quality. In Germany, regulatory bodies and Notified Bodies will look closely at your QMS evidence to ensure you have a strong system in place.

3. Clinical Evaluation

Intraocular Lenses must comply with Annex XIV of the MDR 2017/745. Clinical data must be provided to demonstrate that the materials used are safe for use in the body (biocompatible), optical quality, mechanical strength and outcomes after surgery. If there is insufficient clinical data available, then formal clinical investigation must be undertaken. This must be undertaken in accordance with ISO 14155 standards.

4. Technical Documentation

Technical documentation must be easily found and well organised. This must contain the following details (Annex II and III of EU MDR):

5. Notified Body

Manufacturers will need to work with a Notified Body designated under the EU MDR 2017/745 for Class III Intraocular Lenses. This company will audit your ISO 13485 QMS, review your technical documentation, clinical data and safety performance to issue your EU technical documentation and QMS certificates.

6. EU Declaration of Conformity

When the Notified Body has confirmed your device complies and has issued their certificate(s), the manufacturer can write and sign the legally binding EU Declaration of Conformity (DoC). This proves that the Intraocular Lens complies with all requirements of the MDR 2017/745.

7. CE Marking

Once CE certification has been obtained, the CE Mark (with 4 digit number of the Notified Body) can be applied onto your device. It can be placed on device labelling and packaging so it can be legally sold in Germany and across the EU.

 

Regulatory Considerations for IOL Manufacturers in Germany

In Germany the Federal Institute for Drugs and Medical Devices (BfArM) works with the States to regulate Medical Devices. Manufacturers/Authorized Reps importing IOLs to Germany must ensure that they are compliant with:

  • The German Medical Device Implementation Act (MPDG)
  • Timely registration of Actors and Devices/UDI’s in EUDAMED.
  • Reporting Serious incidents and Field Safety Corrective Actions (FSCA) within the statutory timeframes.

If you are a non EU manufacturer you must also have an appointed EC Representative (EC REP).

Key MDR Technical Requirements for Intraocular Lenses

  • Material Biocompatibility: IOL materials (e.g., hydrophobic acrylic, silicone, PMMA) must pass cytotoxicity and sensitization tests.
  • Optical Performance: Verification of power accuracy, resolution, and stability over time.
  • Sterilization Validation: Compliance with ISO 11135 or ISO 17665 for ethylene oxide or steam sterilization.
  • Labeling and UDI: MDR-compliant labeling with Unique Device Identification (UDI) for traceability.
  • Post-Market Surveillance: Continuous monitoring and reporting of adverse events through PMS and PMCF (Post-Market Clinical Follow-up).

Accelerating CE Marking for Intraocular Lenses with Operon Strategist

Operon Strategist are experts who provide support and guidance to Ophthalmic manufacturers and innovators both domestically and internationally. With over 10+ years of Medical Device experience.

  • EU MDR Device Classification & Gap Analysis: Understanding your IOL range against the new EU MDR 2017/745 classification requirements (Annex VIII)
  • Device Technical Documentation & CER: Development of compliant Device Technical Documentation (Annex II & III). GSPR checklist. Clinical Evaluation Reports (Annex XIV).
  • ISO 13485 QMS: ISO 13485 QMS development and auditing for sterile class III devices.
  • Clinical Investigations & PMCF: Clinical Investigation development ISO14155 and  PMCF (Post-Market Clinical Follow-up).
  • Notified Body: Application management, technical queries and Notified Body visits.
  • Sustainable Post-Market Compliance: Sustainable PMS, PSUR and BfArM Vigilance Development.

FAQ

Under Annex VIII of EU MDR 2017/745, Intraocular Lenses are classified as Class III implantable medical devices, requiring mandatory Notified Body conformity assessment.

Under EU MDR, claiming equivalence for Class III implantable devices is strictly restricted; manufacturers generally need their own clinical investigation data unless they hold a formal contract granting full access to the equivalent device’s technical documentation.

Manufacturers must provide ISO 10993 biocompatibility testing (cytotoxicity, sensitization, ocular implantation), ISO 11979 optical and mechanical performance data (dioptric power, MTF resolution), and ISO 11135/17665 sterilization validation.

Non-EU manufacturers must appoint a European Authorized Representative (EC REP), complete EUDAMED actor and UDI registrations, and ensure compliance with Germany’s MPDG and BfArM vigilance requirements.

Yes, Article 18 of EU MDR requires manufacturers of implantable devices like IOLs to supply an implant card and patient information identifying the device, serial/lot number, UDI, and manufacturer details.

Picture of Sanket Bharat Bhadange
Sanket Bharat Bhadange

Senior Regulatory Affairs Executive | 4 Years of Experience
Medical device regulatory professional specializing in EU MDR 2017/745 technical documentation, CE marking, risk management, clinical and biological evaluation, and post-market surveillance. His expertise includes SFDA MDMA submissions, CDSCO licensing, ISO 13485, MDSAP, US FDA regulatory requirements, and BIS certification.

Table of Contents

Subscribe Newsletter

Talk to our experts

Talk To Our Experts

Have questions about regulatory compliance? Share your requirements and our experts will help you find the right solution.